CTEV Stock Summary and Trading Ideas (Claritev Class A | NYSE:CTEV)

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Claritev Class A trades on the NYSE stock market under the symbol CTEV.

As of March 18, 2026, CTEV stock price declined to $16.28 with 108,335 million shares trading.

CTEV has a beta of 1.49, meaning it tends to be more sensitive to market movements. CTEV has a correlation of 0.04 to the broad based SPY ETF.

CTEV has a market cap of $269.04 million. This is considered a Small Cap stock.

Last quarter Claritev Class A reported $247 million in Revenue and -$4.88 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$3.81.

The top ETF exchange traded funds that CTEV belongs to (by Net Assets): VTI, IWM, FNDA, VXF, IWO.

CTEV has underperformed the market in the last year with a price return of -19.5% while the SPY ETF gained +17.9%. CTEV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -57.6% and -3.7%, respectively, while the SPY returned -1.2% and -2.8%, respectively.

CTEV support price is $15.61 and resistance is $18.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.